Determination of inhibitory potency of argatroban toward thrombin by electrophoretically mediated microanalysis

L. Pochet, C. Bouckaert, A.-C. Servais, E. Farcas, V. Bettonville, M. Fillet

Research output: Contribution to journalArticle

Abstract

Developing an EMMA method for enzymatic assay remains a challenge, particularly using UV detection. Indeed, it is necessary to optimize the separation conditions while allowing the enzymatic reaction to occur within the capillary respecting kinetic constraints and achieving enough sensitivity. In this work, such EMMA methodology was set up to evaluate the inhibitory potency of drugs toward thrombin, a serine protease implicated in the coagulation cascade. To achieve our goal, the separation buffer, the injection sequence, the internal standard and the chromogenic substrate were investigated. The newly developed system was then assessed determining the kinetic K constant for the selected substrate and compared with the results obtained with a continuous spectrophotometer cell assay. Secondly, the K inhibitory constant of the thrombin inhibitor argatroban was determined and found in agreement with the published value.
Original languageEnglish
Pages (from-to)719-725
Number of pages7
JournalTalanta
Volume116
DOIs
Publication statusPublished - 1 Jan 2013

Fingerprint Dive into the research topics of 'Determination of inhibitory potency of argatroban toward thrombin by electrophoretically mediated microanalysis'. Together they form a unique fingerprint.

  • Cite this